Overview

RAN-FENTANYL MATRIX PATCH 100 MCG contains FENTANYL : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 02330156, held by RANBAXY PHARMACEUTICALS CANADA INC., supplied as PATCH for TRANSDERMAL administration. Nexara Health is a licensed Canadian wholesale distributor and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details

Indications

Management of pain severe enough to require daily, continuous, long-term opioid treatment, that is opioid-responsive and for which alternative options are inadequate. For opioid-tolerant patients.

Dosage and administration

Apply to intact skin for 72 hours. Initial dose based on conversion from prior opioids; must not exceed equivalent dose. Titrate using 12 mcg/h increments. Do not use for acute pain.

Contraindications

Acute/perioperative pain; mild/intermittent pain; opioid-naive patients; severe respiratory depression; severe asthma; GI obstruction; head injury; MAO inhibitors; pregnancy/breast-feeding.

Warnings and precautions

Risk of addiction, abuse, and misuse. Fatal respiratory depression may occur. Accidental exposure can be fatal. Avoid external heat sources. Monitor for bradycardia.

Storage and handling

Not specified in the provided text (referred to section 28 which is not in the snippet). Typical storage is 15-30°C.

Packaging

Not explicitly detailed in provided text beyond strengths (12, 25, 50, 75, 100 mcg/h) and mention of sealed packages/protective liners.

Alternatives in the same therapeutic class

Products sharing ATC code N02AB03 FENTANYL. Marketed products are listed first. Substitution decisions rest with the prescriber or pharmacist, and interchangeability is determined provincially.